Nephro Care India Q2 FY27 Consolidated Net Profit Rises 6.3% YoY to ₹2.76 Crore
Nephro Care India Ltd · Outcome · 12 Nov 2026, 11:40 pm
Nephro Care India Q2 FY27 Consolidated Net Profit Rises 6.3% YoY to ₹2.76 Crore Nephro Care India reported a consolidated revenue from operations of ₹33.30 crore for the quarter ended 30th Sep'26, up 51.4% YoY from ₹21.99 crore and up 14.1% QoQ from ₹29.19 crore. Consolidated net profit reached ₹2.76 crore compared to ₹2.59 crore in 30th Sep'25 and ₹1.61 crore in 30th Jun'26, with diluted EPS at ₹1.67. For H1 FY27, revenue climbed 58.9% YoY to ₹62.49 crore, while net profit grew 124.5% YoY to ₹4.36 crore. Additionally, IPO proceeds of ₹36.18 crore stand fully utilized.
Original exchange filing (PDF)
More announcements from Nephro Care India Ltd
- Nephro Care India Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 · 12 Nov 2026
- Nephro Care India Limited has informed the Exchange about related Party Transactions · 12 Nov 2026
- Nephro Care India Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 12 Nov 2026
- NEPHRO CARE INDIA LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 12 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 12 Nov 2026
- SDD Certificate for the quarter ended 30th September 2026 · 05 Oct 2026
- Nephro Care India Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the quarter ended 30th September 2026 · 01 Oct 2026
- Nephro Care India Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 25, 2026. Further, the company has informed the Exchange regarding voting results. · 28 Sept 2026
